Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey-Reference-Cited by-同舟云学术

Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey

Published:2017-12-07 Issue:1 Volume:31 Page:e12565
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Potenza Maria C.¹,Peris Ketty²,Berardesca Enzo³,Bianchi Luca⁴,Richetta Antonio⁴⁵,Bernardini Nicoletta¹,De Simone Clara²,Teoli Miriam⁴,Zangrilli Arianna⁴,D'epiro Sara⁵,Orsini Diego⁶,Narcisi Alessandra⁶⁷,Chimenti Sergio⁴,Costanzo Antonio⁷⁸^ORCID

Affiliation:

1. UOC di Dermatologia “Daniele Innocenzi”, Università degli Studi “Sapienza” Roma I facoltà di Medicina e Chirurgia, Polo Pontino; Terracina LT Italy

2. Istituto di Dermatologia Policlinico Gemelli; Rome Italy

3. Ambulatorio Psoriasi IFO-San Gallicano; Rome Italy

4. Clinica Dermatologica, Dipartimento di Medicina dei Sistemi, Universita Tor Vergata; Rome Italy

5. Centro psoriasi, Dipartimento di Medicina Interna e Specialità Mediche, Università “La Sapienza” Policlinico Umberto I; Rome Italy

6. Clinica Dermatologica, Dipartimento di Neuroscienze Salute Mentale e Organi di Senso (NESMOS); Università Sapienza- Azienda Ospedaliera Sant'Andrea; Rome Italy

7. Humanitas Clinical and Research Center; Skin Pathology Lab; Rozzano-Milan Italy

8. Dermatology Unit, Department of Biomedical Sciences; Humanitas University; Rozzano-Milan Italy

Funder

European Commission

Italian Ministry of Health project

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dth.12565/fullpdf

Reference52 articles.

1. Efficacy of adalimumab in the treatment of moderate-to-severe psoriasis: A retrospective study of 100 patients in daily practice;Armesto;Journal of Dermatological Treatment,2015

2. Anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: Focus on adalimumab;Armuzzi;International Journal of Immunopathology Pharmacology,2014

3. The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases;Blandizzi;International Journal of Immunopathology Pharmacology,2014

4. Blandizzi , C. 2013 http://www.sifweb.org/docs/sif_position_paper_anti_tnf_giu13.pdf

5. Drug survival rates of biologic treatments in patients with psoriasis vulgaris;Brunasso;British Association of Dermatologists,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiome profile in psoriatic patients treated and untreated with biologic therapy;The Journal of Dermatology;2021-01-28

2. Biologic Drug Survival in Psoriasis: A Systematic Review & Comparative Meta-Analysis;2020-07-15

3. Patients’ Perspectives and Experience of Psoriasis and Psoriatic Arthritis: A Systematic Review and Thematic Synthesis of Qualitative Studies;Arthritis Care & Research;2020-04-28

4. Biologics for psoriasis: What is new?;Dermatologic Therapy;2019-04-25